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Dr Richard-Tien V. Ha (Stanford, Calif). Dr Osaki, thank you
for providing me the manuscript ahead of time and also
congratulations on the research that you have done. I think this
is something that we will be talking about more in the future.
As you know, your laboratory, as well as other laboratories,
have looked at animal hearts in the DCD condition. And although
those results have been promising, there are a lot of hurdles to
overcome. I listened with interest to your presentation and read
your manuscript. And I think what stands out is that you used hu-
man hearts really for the first time in a DCD condition and used an
ex vivo apparatus to try to recondition or look at their function.
The other thing that was very interesting about your paper was
the fact that you chose to use a functional, or at least start to use a
functional assessment rather than just biochemical assessments for
the hearts, which is something novel as well.
To that end I have 2 questions for you.
The first question relates to the functional assessment. And you
mentioned that it was a nonworking heart model, but in the future
do you plan to assess a working heart model where you vary the
preload and the afterload and challenge the heart in that condition?
The second question is: the studies that have been done by Ali
and other laboratories in animals have looked at and discussed
that the RV is actually a key component in the failure of
these DCD hearts. Did you observe the RV at all during this
time—understandably it’s in a Langendorff model—or are you
planning to do that in the future?
Dr Osaki. Thank you very much, Dr Ha. It’s a very good
comment.
For the first question, actually we didn’t change the afterload
but we changed the preload by the balloon volume. Yes, absolutely,
in the future, we need to do an in vivo setting as a nice functional
variation.
And also the second question, in this study we didn’t look at the
right heart function; as we know, there is 1 case report for
biventricular functional evaluation for the human DCD heart,
and that’s a great study. Yes, absolutely, we are planning to do
biventricular function analysis.gery c September 2014
